SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
44 John started a new thread this morning, posting the memantine-related release bscaram(o)uche-12/18/1996
43 Michael... its just a gut feeling that there will continue to be problems with Boyce Burge-11/21/1996
42 Rick, Have you heard anything from the Annual meeting? I've haven't seeJohan Van Houtven-11/16/1996
41 NTII annual meeting. Anyone planning on attending the annual meeting tomorrow? John Wright-11/13/1996
40 I finally got SI registration through Lynx! I am glad to be in this forum. Hi esemi2000-11/10/1996
39 Mr. de Castro, NTII indeed handles it's PR very badly. One can only wonder Johan Van Houtven-11/8/1996
38 Things at NTII are not as bad as they appear. I've learned that Michael OstDr. John M. de Castro-11/8/1996
37 In my mind Ostrach's leaving does not lessen the value of Memantine, my maiRobert Cohen-11/6/1996
36 >>>Ostrach the $7m man. Robert, if the company or Ostrach could have John Wright-11/6/1996
35 Ostrach's leaving was signaled in the annual meeting notice dated October 1Robert Cohen-11/6/1996
34 Some background info about the head honchos at NTII. (For those of you who haveJohan Van Houtven-11/5/1996
33 None.P. Ramamoorthy-11/5/1996
32 Some new news. Any insight? RICHMOND, Calif., Nov. 4 /PRNewswire/ -- NeClive Roberts-11/4/1996
31 Rick and John, Glad to see you both here. RamP. Ramamoorthy-10/30/1996
30 I'm an owner of NTII, having been educated by John DeCastro and impressed wRobert Cohen-10/29/1996
29 Actually I agree with both Rick and John de regarding certain points. 1. It mJames Silverman-10/29/1996
28 Message from John Metcalf on Oct 29 1996 5:18PM EST CNSI's rival neuscaram(o)uche-10/29/1996
27 CNSI's rival neuronal calcium channel blocker, Cerestat, is in Phase III trJohn Metcalf-10/29/1996
26 Message from Dr. John M. de Castro on Oct 29 1996 9:30AM EST Rick, scaram(o)uche-10/29/1996
25 Rick, Actually partnering memantine at this time is not a good idea for NTDr. John M. de Castro-10/29/1996
24 Message from John Metcalf on Oct 20 1996 9:53PM EST All three products ascaram(o)uche-10/27/1996
23 All three products are in clinical trials. News could come from any direction.John Metcalf-10/20/1996
22 Clive, are you talking about Somatogen or ImmuLogic????Michael Collins-10/20/1996
21 My question is ....when is there likely to be action on this stock, as its beenClive Roberts-10/20/1996
20 Rick, no I'm not the scientist you refer to though I wish I was - maybe it Michael Collins-10/15/1996
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News